Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220886052> ?p ?o ?g. }
- W4220886052 endingPage "100518" @default.
- W4220886052 startingPage "100518" @default.
- W4220886052 abstract "Changes in ABO blood type caused by a gradual decrease in antigen expression have been found in patients with acute myeloid leukemia (AML). Studies have indicated that alteration of ABO gene methylation accounts for 50% of acquired weak ABO antigen expression in patients with leukemia. However, the molecular mechanisms contributing to the remaining 50% of cases are unknown. We hypothesize that deregulation of miRNA is correlated with weak ABO antigen expression in patients with AML. Blood samples of 19 patients with AML and 12 healthy controls were collected, in which the blood type was not changed in these AML patients. Flow cytometric analysis was applied to measure the ABO antigen expression titer among AML patients and controls. A total of 18 leukemia-related miRNAs were analyzed via quantitative real-time polymerase chain reactions. We found that miRNA profiles were correlated with the AML patients, especially in those who had constant or weakened ABO antigen expressions. Compared with healthy controls, the miR-16 and miR-451 expression were significantly lower in either AML cases with weak ABO antigen expressions (p = 0.003, p = 0.028, respectively) or AML cases with constant ABO antigen expressions (p = 0.043, p = 0.040, respectively). Although not statistically significant, decreasing trends in the miR-451 and miR-16 expressions in the AML patients with weakened ABO were observed compared to those with constant ABO antigens. The weak ABO antigen expression might correlate with miRNAs, especially miR-16 and miR-451. This study indicated that decreasing in miR-16 and miR-451 was associated with AML and AML with weakened ABO expression. In the future, we will continue to include more cases and exclude the others factor influencing ABO antigen expression, promoter methylation and oxidative stress, to replicate the results of this study and investigate the underlying mechanism of decreasing miR-16 and miR-451 in AML patients with varied ABO antigen expression levels." @default.
- W4220886052 created "2022-04-03" @default.
- W4220886052 creator A5024395460 @default.
- W4220886052 creator A5051132978 @default.
- W4220886052 creator A5077548608 @default.
- W4220886052 creator A5085785975 @default.
- W4220886052 date "2023-04-01" @default.
- W4220886052 modified "2023-10-16" @default.
- W4220886052 title "Association between diminished miRNA expression and the disease status of AML patients: Comparing to healthy control" @default.
- W4220886052 cites W14098964 @default.
- W4220886052 cites W1798925251 @default.
- W4220886052 cites W1969199788 @default.
- W4220886052 cites W1972064898 @default.
- W4220886052 cites W1974261530 @default.
- W4220886052 cites W1985081669 @default.
- W4220886052 cites W1997424007 @default.
- W4220886052 cites W2007096007 @default.
- W4220886052 cites W2008061500 @default.
- W4220886052 cites W2015311527 @default.
- W4220886052 cites W2043973101 @default.
- W4220886052 cites W2048902349 @default.
- W4220886052 cites W2048991481 @default.
- W4220886052 cites W2049642466 @default.
- W4220886052 cites W2053199751 @default.
- W4220886052 cites W2057100799 @default.
- W4220886052 cites W2059382687 @default.
- W4220886052 cites W2062396541 @default.
- W4220886052 cites W2062625397 @default.
- W4220886052 cites W2070651992 @default.
- W4220886052 cites W2072940536 @default.
- W4220886052 cites W2073487367 @default.
- W4220886052 cites W2087206434 @default.
- W4220886052 cites W2090632234 @default.
- W4220886052 cites W2092326426 @default.
- W4220886052 cites W2092840595 @default.
- W4220886052 cites W2099096369 @default.
- W4220886052 cites W2107277218 @default.
- W4220886052 cites W2107501691 @default.
- W4220886052 cites W2110378853 @default.
- W4220886052 cites W2125939997 @default.
- W4220886052 cites W2150740663 @default.
- W4220886052 cites W2156629568 @default.
- W4220886052 cites W2168306631 @default.
- W4220886052 cites W2192080449 @default.
- W4220886052 cites W2337290195 @default.
- W4220886052 cites W2411000180 @default.
- W4220886052 cites W2431984666 @default.
- W4220886052 cites W2530597079 @default.
- W4220886052 cites W2583835565 @default.
- W4220886052 cites W2749384456 @default.
- W4220886052 cites W2751026518 @default.
- W4220886052 cites W2789466499 @default.
- W4220886052 cites W2938742925 @default.
- W4220886052 cites W2963552158 @default.
- W4220886052 cites W2968740435 @default.
- W4220886052 cites W2982592754 @default.
- W4220886052 cites W4367435876 @default.
- W4220886052 doi "https://doi.org/10.1016/j.bj.2022.03.003" @default.
- W4220886052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35307582" @default.
- W4220886052 hasPublicationYear "2023" @default.
- W4220886052 type Work @default.
- W4220886052 citedByCount "1" @default.
- W4220886052 countsByYear W42208860522023 @default.
- W4220886052 crossrefType "journal-article" @default.
- W4220886052 hasAuthorship W4220886052A5024395460 @default.
- W4220886052 hasAuthorship W4220886052A5051132978 @default.
- W4220886052 hasAuthorship W4220886052A5077548608 @default.
- W4220886052 hasAuthorship W4220886052A5085785975 @default.
- W4220886052 hasBestOaLocation W42208860521 @default.
- W4220886052 hasConcept C104317684 @default.
- W4220886052 hasConcept C145059251 @default.
- W4220886052 hasConcept C147483822 @default.
- W4220886052 hasConcept C176080213 @default.
- W4220886052 hasConcept C203014093 @default.
- W4220886052 hasConcept C2778461978 @default.
- W4220886052 hasConcept C2778729363 @default.
- W4220886052 hasConcept C2779282312 @default.
- W4220886052 hasConcept C54355233 @default.
- W4220886052 hasConcept C71924100 @default.
- W4220886052 hasConcept C86803240 @default.
- W4220886052 hasConceptScore W4220886052C104317684 @default.
- W4220886052 hasConceptScore W4220886052C145059251 @default.
- W4220886052 hasConceptScore W4220886052C147483822 @default.
- W4220886052 hasConceptScore W4220886052C176080213 @default.
- W4220886052 hasConceptScore W4220886052C203014093 @default.
- W4220886052 hasConceptScore W4220886052C2778461978 @default.
- W4220886052 hasConceptScore W4220886052C2778729363 @default.
- W4220886052 hasConceptScore W4220886052C2779282312 @default.
- W4220886052 hasConceptScore W4220886052C54355233 @default.
- W4220886052 hasConceptScore W4220886052C71924100 @default.
- W4220886052 hasConceptScore W4220886052C86803240 @default.
- W4220886052 hasFunder F4320323441 @default.
- W4220886052 hasIssue "2" @default.
- W4220886052 hasLocation W42208860521 @default.
- W4220886052 hasLocation W42208860522 @default.
- W4220886052 hasLocation W42208860523 @default.
- W4220886052 hasOpenAccess W4220886052 @default.
- W4220886052 hasPrimaryLocation W42208860521 @default.